Related Experiment Video
Updated: Aug 12, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Prophylactic high-frequency oscillatory ventilation in preterm infants
1Neonatal Unit, Department of Child Health, St George's Hospital, London SW17 0RE, UK. scalvert@sghms.ac.uk
Insights
High-frequency oscillatory ventilation (HFOV) may reduce chronic lung disease in preterm infants. Further evaluation is needed to confirm its benefits and assess neurological outcomes in very premature infants.
Area of Science:
- Neonatal Medicine
- Respiratory Physiology
- Pediatric Critical Care
Background:
- The efficacy of high-frequency oscillatory ventilation (HFOV) for treating respiratory distress in preterm infants is not definitively established.
- Previous trials comparing HFOV with conventional ventilation (CV) suggest a potential reduction in chronic lung disease (CLD).
- Limitations in existing studies and concerns regarding potential increases in intracranial pathology in very premature infants necessitate further research.
Purpose of the Study:
- To conclusively determine the role of prophylactic HFOV in preventing CLD in infants born before 29 weeks of gestational age.
- To evaluate the short-term and long-term respiratory and neurological outcomes associated with prophylactic HFOV.
Main Methods:
- Conducted the UKOS trial, a large, UK-based, multicenter randomized trial.
- Compared prophylactic HFOV with conventional ventilation (CV) in a cohort of preterm infants born prior to 29 weeks of gestational age.
Main Results:
- Results from previous trials suggest HFOV may decrease the incidence of CLD in preterm infants.
- However, these trials had limitations, and the impact of HFOV on intracranial pathology remains unclear.
Conclusions:
- Further comprehensive evaluation of prophylactic HFOV is required.
- Emphasis should be placed on assessing both short-term and long-term respiratory and neurological outcomes.
Unlabelled:
The role of high-frequency oscillatory ventilation (HFOV) for the treatment of respiratory disease in preterm infants remains uncertain. Several randomized trials, comparing HFOV and conventional ventilation (CV) have been performed and their results suggest that HFOV may reduce the incidence of chronic lung disease (CLD) in preterm infants. However, the trials have several limitations and it remains unclear whether HFOV might increase intracranial pathology in very prematurely born infants. UKOS, a large, UK-based, multicentre trial was conducted to establish conclusively the role of prophylactic HFOV for the prevention of CLD in infants born prior to 29 wk of gestational age.
Conclusion:
There is still a need to fully evaluate prophylactic HFOV with particular emphasis on both short and long term respiratory and neurological outcomes.
Related Concept Videos
Tracheostomy Suctioning I: Pre-Procedural Steps
Equipment Required
First, gather all necessary equipment: a sterile suction catheter, a sterile disposable container, sterile gloves, a towel or...
Mechanical Ventilation I: Indication and Settings
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Ventilatory Modes
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
Respiratory Syncytial Virus Disease

